---
figid: PMC7720688__00405-2020.05
figtitle: Schematic summary of the potential therapeutic targets
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Adenoviridae
- Influenza A virus
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Middle East respiratory syndrome-related coronavirus
- Respiratory syncytial virus
- Adeno-associated virus
- H5N1 subtype
- Enterovirus
- Bat SARS-like coronavirus
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Cricetus cricetus
- Felis catus
- Mesocricetus auratus
- Mustela putorius furo
- Panthera tigris
- Homo sapiens
- Macaca mulatta
- Schistosoma mansoni
- NA
organisms_ner:
- Mus musculus
- Drosophila melanogaster
pmcid: PMC7720688
filename: 00405-2020.05.jpg
figlink: pmc/articles/PMC7720688/figure/F5/
number: F5
caption: Schematic summary of the potential therapeutic targets. Recapitulation of
  coronavirus disease 2019 (COVID-19) pathological conditions in global or cell-specific
  knockouts in the humanised angiotensin-converting enzyme (hACE2) mouse model will
  enable investigators to dissect the inflammatory immune cascades that are involved
  in disease pathology. As shown, the blockade of cell-specific receptors, T-helper
  (Th)1 and/or Th2 cytokines, complement activation, renin–angiotensin system pathway
  activity, administration of mesenchymal stem cells, and antithrombotic treatments
  could all be useful as therapeutic targets in COVID-19.
papertitle: Pathophysiology and potential future therapeutic targets using preclinical
  models of COVID-19.
reftext: Rahul Kumar, et al. ERJ Open Res. 2020 Oct;6(4):00405-2020.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6310995
figid_alias: PMC7720688__F5
figtype: Figure
redirect_from: /figures/PMC7720688__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7720688__00405-2020.05.html
  '@type': Dataset
  description: Schematic summary of the potential therapeutic targets. Recapitulation
    of coronavirus disease 2019 (COVID-19) pathological conditions in global or cell-specific
    knockouts in the humanised angiotensin-converting enzyme (hACE2) mouse model will
    enable investigators to dissect the inflammatory immune cascades that are involved
    in disease pathology. As shown, the blockade of cell-specific receptors, T-helper
    (Th)1 and/or Th2 cytokines, complement activation, renin–angiotensin system pathway
    activity, administration of mesenchymal stem cells, and antithrombotic treatments
    could all be useful as therapeutic targets in COVID-19.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ace2
  - Hand2
  - Hand1
  - Nelfcd
  - ras
  - Hras
  - Kras
  - Rem1
  - Ace
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - TH1
  - Ras64B
  - Ras85D
  - Coagulopathy
  - thrombosis
  - COVID-19
---
